» Articles » PMID: 36404989

Prohibitins in Neurodegeneration and Mitochondrial Homeostasis

Overview
Journal Front Aging
Specialty Geriatrics
Date 2022 Nov 21
PMID 36404989
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of age-related neurodegenerative disorders has risen with the increase of life expectancy. Unfortunately, the diagnosis of such disorders is in most cases only possible when the neurodegeneration status is already advanced, and symptoms are evident. Although age-related neurodegeneration is a common phenomenon in living animals, the cellular and molecular mechanisms behind remain poorly understood. Pathways leading to neurodegeneration usually diverge from a common starting point, mitochondrial stress, which can serve as a potential target for early diagnosis and treatments. Interestingly, the evolutionarily conserved mitochondrial prohibitin (PHB) complex is a key regulator of ageing and metabolism that has been associated with neurodegenerative diseases. However, its role in neurodegeneration is still not well characterized. The PHB complex shows protective or toxic effects in different genetic and physiological contexts, while mitochondrial and cellular stress promote both up and downregulation of PHB expression. With this review we aim to shed light into the complex world of PHB's function in neurodegeneration by putting together the latest advances in neurodegeneration and mitochondrial homeostasis associated with PHB. A better understanding of the role of PHB in neurodegeneration will add knowledge to neuron deterioration during ageing and help to identify early molecular markers of mitochondrial stress. This review will deepen our understanding of age-related neurodegeneration and provide questions to be addressed, relevant to human health and to improve the life quality of the elderly.

Citing Articles

UBXN1 promotes liver tumorigenesis by regulating mitochondrial homeostasis.

Jiao K, Xu G, Liu Y, Yang Z, Xiang L, Chen Z J Transl Med. 2024; 22(1):485.

PMID: 38773518 PMC: 11110256. DOI: 10.1186/s12967-024-05208-5.


and protect against decreased KCC2 expression induced by the lipopolysaccharide treatment in PC-12 cells and improve behavioral abnormalities in male mice.

Tomita K, Oohara Y, Igarashi K, Kitanaka J, Kitanaka N, Tanaka K Heliyon. 2023; 9(12):e22784.

PMID: 38090003 PMC: 10711140. DOI: 10.1016/j.heliyon.2023.e22784.

References
1.
Dugger B, Dickson D . Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol. 2017; 9(7). PMC: 5495060. DOI: 10.1101/cshperspect.a028035. View

2.
Merkwirth C, Martinelli P, Korwitz A, Morbin M, Bronneke H, Jordan S . Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration. PLoS Genet. 2012; 8(11):e1003021. PMC: 3493444. DOI: 10.1371/journal.pgen.1003021. View

3.
Kuadkitkan A, Wikan N, Fongsaran C, Smith D . Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology. 2010; 406(1):149-61. DOI: 10.1016/j.virol.2010.07.015. View

4.
Anderson C, Kahl A, Qian L, Stepanova A, Starkov A, Manfredi G . Prohibitin is a positive modulator of mitochondrial function in PC12 cells under oxidative stress. J Neurochem. 2018; 146(3):235-250. PMC: 6105506. DOI: 10.1111/jnc.14472. View

5.
Slota L, Miranda E, McClay D . Spatial and temporal patterns of gene expression during neurogenesis in the sea urchin . Evodevo. 2019; 10:2. PMC: 6371548. DOI: 10.1186/s13227-019-0115-8. View